Viyash Scientific Ltd.

₹191.76

-1.2 (-0.6%)

VIYASH Share Price

Pharmaceuticals & Biotechnology

As on April 2, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 8,774 Cr

P/E Ratio303.9

Dividend YieldN/A

Trendline Performance

We are partnered with TradingView, a global leader in charting and market analysis. Access real-time stock data, explore the powerful Stock Screener , and uncover insights with multiple tools designed for traders.

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	189.75	Bullish
10-DMA	189.09	Bullish
20-DMA	193.04	Bearish
50-DMA	203.49	Bearish
100-DMA	208.86	Bearish
200-DMA	199.25	Bearish

Historical Performance

1 Year

39.8%

3 Years

164.1%

5 Years

-21.4%

10 Years

29%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Net Sales	15,514	13,697	14,209	14,128	13,616
Total Expenditure	13,925	13,083	14,090	13,034	11,517
Other Income	176	110	64	109	105
Operating Profit	1,765	724	183	1,202	2,204
Interest	608	481	355	158	244
Depreciation	665	615	557	515	506
Profit Before Tax	443	-546	-1,377	529	1,366
Consolidated Net Profit	219	-359	-1,212	410	954
Adjusted EPS	1	-1	-5	2	4

Compounded Sales Growth

10 Years:-14.2

5 Years:-4.7

3 Years:-4.1

TTM:1.1

Compounded Profit Growth

10 Years:-31.5

5 Years:-5.8

3 Years:1.3

TTM:91

Stock Price CAGR

10 Years:2.6

5 Years:-4.7

3 Years:37.7

TTM:34.4

Return on Equity

10 Years:0.4

5 Years:1.3

3 Years:-0.2

last year:0.6

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2025	Mar-2024	Mar-2023	Mar-2022	Mar-2021
Share Capital	501	499	499	497	497
Total Reserves	5,576	5,294	5,926	5,953	6,702
Long-Term Borrowings	---	---	---	---	---
Total Non-Current Liabilities	2,632	1,726	1,758	2,091	1,536
Other Current Liabilities	680	1,186	1,096	790	1,006
Short Term Borrowings	1,609	2,459	1,821	1,595	1,029
Total Liabilities	15,721	15,311	14,838	14,866	14,430
Capital Work in Progress	151	111	514	88	288
Long Term Loans & Advances	553	695	217	540	322
Currents Investments	1	26	---	14	57
Short Term Loans and Advances	802	648	432	628	775
Total Current Assets	9,065	8,295	7,798	8,084	7,667
Total Assets	15,721	15,311	14,838	14,866	14,430
Adjusted Book Value	24	23	26	26	29

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 303.9, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a strong 3-year price CAGR of 37.8%, indicating sustained price appreciation.
The stock carries a high beta of 1.4, implying higher volatility and elevated risk.
In the last financial year, the company reported an EBITDA of ₹396 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1783 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 1343986.5

No. of Shares: 7009 (Approx)

Performance:34.4%

P/L: ₹343986.5

NIFTY Performance: -2.3%

1 day Top Gainers